Infectious Disease Control

Moscow ranked first among European cities in the ranking of innovations against COVID-19

Moscow ranks third in the world, behind New York and San Francisco MOSCOW, Dec. 7, 2021 /PRNewswire/ -- Moscow is recognized as the first European city in the ranking of innovations, that are used for the formation of resilience to the coronavirus. It is ahead ofLondon and Barcelona. The Russian...

2021-12-07 02:34 3229

RedHill Biopharma Reports that Opaganib Mechanism Not Impacted by Viral Spike-Protein Mutations, Including Omicron Mutations

Unique Mode of Action Opaganib works by targeting the human host cell rather than the virus itself and is therefore not expected to be impacted by spike protein mutations, providing a strong rationale for its potential to address the Omicron SARS-CoV-2 variant, as well as other variants of conce...

2021-12-06 20:01 3662

Brii Biosciences Included in Hong Kong Stock Connect

DURHAM, N.C. and BEIJING, Dec. 6, 2021 /PRNewswire/ -- Brii Biosciences  Limited ("Brii Bio" or the "Company", stock code: 2137.HK), today announced that the Company has been added to the Hong Kong Stock Connect. This inclusion allows eligible domestic investors...

2021-12-06 10:54 3179

Starpharma signs distribution agreement for VIRALEZE™ antiviral nasal spray in Vietnam

* Starpharma has signed a 5-year supply and distribution agreement for VIRALEZE™ inVietnam * The agreement includes a minimum commitment of 1 million units in the first year * VIRALEZE™ is scheduled to be officially launched in Vietnam today, following its registration for sale this week ...

2021-12-03 14:24 2650

CGTN: Peng Liyuan sends message to Linfen Red Ribbon School students on World AIDS Day

BEIJING, Dec. 2, 2021 /PRNewswire/ -- Peng Liyuan, wife of Chinese President Xi Jinping and the World Health Organization (WHO)'s goodwill ambassador for tuberculosis and HIV/AIDS, sent a video message to the students of the Linfen Red Ribbon School in northChina's Shanxi Province at an event mar...

2021-12-02 13:03 3233

Cue Health Receives Singapore HSA Authorization for its Molecular COVID-19 Test for Self-Testing

- The Cue COVID-19 Test was authorized for self-testing by the Singapore Health Sciences Authority (HSA) through its Pandemic Special Access Route (PSAR) - The HSA authorization of the Cue COVID-19 Test is for home use in both symptomatic and asymptomatic users, ages 2 years and up - Cue Health ...

2021-12-02 02:28 1654

World Federation of Neurology Impresses Importance of Brain Health Through Global Public Initiative

LONDON, Dec. 1, 2021 /PRNewswire/ -- The World Federation of Neurology (WFN) is leading the charge on advocating for brain health awareness, through the launch of its Brain Health Initiative (BHI), a program created to reduce the immense global burden of brain diseases and disorders. Neurological...

2021-12-01 16:22 1851

EpiVax Progresses on a Vaccine to Address SARS-CoV-2 Variants

PROVIDENCE, R.I., Dec. 1, 2021 /PRNewswire/ -- Today EpiVax, Inc. ("EpiVax") confirmed that the company'sEPV-CoV-19 vaccine epitopes are 98.2% conserved in the new Omicron SARS-CoV-2 variant. EpiVax and EpiVax Therapeutics, Inc. ("EVT") are also affirming commitment to move the novel T cell epito...

2021-12-01 05:22 1900

New CELLSEARCH® Circulating Multiple Myeloma Test now available to help community physicians optimize patient care

As the market leader in cell-based liquid biopsies, Menarini Silicon Biosystems is offering community hematology-oncologists an opportunity to have patient blood samples sent to a US centralized laboratory where itsCELLSEARCH®    technology can enumerateCirculating Multiple Myeloma Cells (CMMCs) f...

2021-11-30 22:18 2361

Seegene's High Multiplex PCR Assay Capable of Detecting New Omicron Variant

SEOUL, South Korea, Nov. 30, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530),  South Korea's leading molecular diagnostics company, today confirmed that its Allplex™ SARS-CoV-2 Master Assay is capable of detecting the Omicron's unique pattern of mutations. The well-established PCR-based test recogni...

2021-11-30 19:25 2480

JOYSBIO's SARS-COV-2 Antigen Rapid test detects OMICRON variant

TIANJIN, China, Nov. 30, 2021 /PRNewswire/ -- JOYSBIO, one of the world's leading manufacturers of lateral flow rapid tests, is proud to announce that their tests are available around the world. Furthermore, they've been able to show that their test can detect the new Omicron (B.1.1.529). This va...

2021-11-30 14:00 2292

CGTN: China-Africa friendship continues to flourish on vaccine, trade, renewable energy

BEIJING, Nov. 30, 2021 /PRNewswire/ -- China-Africa friendship is expected to continue to flourish as cooperation is further deepened in various areas after the ongoing 8th Ministerial Conference of the Forum on China-Africa Cooperation (FOCAC) held inDakar, Senegal.   China wi...

2021-11-30 10:03 2777

Biotron Drug Effective Against COVID-19 In Animals

* BIT225 administered orally significantly reduced viral load in the lungs and blood of animals challenged with SARS-CoV-2. * BIT225 protected against severe disease, indicated by the significant prevention of body weight loss in animals treated with BIT225 compared to non-treated controls. ...

2021-11-25 19:00 2153

Innovative €250,000 Parenteral Nutrition Research Grant Awarded by Fresenius Kabi

BAD HOMBURG, Germany, Nov. 25, 2021 /PRNewswire/ -- Fresenius Kabi was delighted to announce the winner of their innovative JUMPstart education program and research grant onSeptember 10, 2021. JUMPstart is an initiative that aims to nurture research in the field of parenteral nutrition through th...

2021-11-25 15:45 3064

Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore

GAITHERSBURG, Md., Nov. 24, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced its submission to the Singapore Health Sciences Authority (HSA) for interim ...

2021-11-24 22:15 2670

Global COVID-19 Safety Innovator Expands Its Offerings

"Investing smartly in the safety of employees." Including, now, a US OSHA COVID-Rules-Compliant SaaS Platform Enhancement BOSTON, Nov. 24, 2021 /PRNewswire/ -- Safely2Prosperity LLC CEO John Norris, JD, MBA, announces S2P's new COVID-19 Safety Platform and Employee Dashboard for quick demonstrat...

2021-11-24 11:42 3927

Laos becomes the 20th country to authorize the one-shot Sputnik Light vaccine

MOSCOW, Nov. 24, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved in Lao People's Democratic Republic. ThusLaos has become the 20th country to ...

2021-11-24 07:47 1532

Seegene Announces Q3 2021 Earnings, Continuing COVID-Era Momentum

* Q3 Revenue held steady at KRW 305.3 billion * Operating profit dipped slight due to powerful investment in R&D * Scheduled to introduce new diagnostic tests capable of screening 22 targets, including3 genes of COVID-19 and 19 respiratory viruses in a single tube  SEOUL, South Korea, Nov. 2...

2021-11-23 16:03 1831

Simcere and Shanghai Institute of Materia Medica Enter a Collaboration to Jointly Develop Next-Gen COVID-19 Oral Antiviral Treatments

NANJING, China, Nov. 22, 2021 /PRNewswire/ -- On November 17, 2021, Simcere Pharmaceutical Group Limited (2096.HK) announced that the company has reached collaboration agreement with the Shanghai Institute ofMateria Medica (SIMM), Chinese Academy of Sciences (CAS), to develop novel antiviral drug...

2021-11-23 11:22 2044

Baidu Enters Into License Agreement With Sanofi to Enable Next-Generation mRNA Therapeutics and Vaccines

BEIJING, Nov. 22, 2021 /PRNewswire/ -- Baidu, Inc. (NASDAQ:BIDU and HKEX:9888), a leading AI company with strong Internet foundation, and Sanofi, a leading biopharmaceutical company focused on human health, have entered into an agreement to integrate Baidu's messenger ribonucleic acid (mRNA) desi...

2021-11-22 20:00 2062
1 ... 20212223242526 ... 79

Week's Top Stories